Feb. 2 at 4:17 PM
$SENS Dexcom Reportedly in Talks to Acquire Senseonics in
$8.2 Billion DealBy
February 2, 2026 Dexcom Inc., a leader in continuous glucose monitoring (CGM) technology, is reportedly in advanced talks to acquire Maryland-based Senseonics Holdings in a deal valued at approximately
$8.2 billion, according to people familiar with the matter. The potential acquisition, if finalized, would mark one of the largest transactions in the diabetes technology sector in recent years. Sources close to the discussions said the two companies have been negotiating terms for several weeks, with Dexcom aiming to strengthen its position in the long-term implantable sensor market, a space where Senseonics has pioneered devices lasting up to six months per insertion. Under the proposed deal, Dexcom would pay a combination of cash and stock to acquire all outstanding shares of Senseonics. The agreement could be announced as early as late February, though talks remain ongoing and could still fall apart.
